Leukemia, Myeloid, Accelerated Phase
Showing 9976 - 10000 of >10,000
NSCLC Trial in United States (erlotinib, bemcentinib)
Completed
- Non-Small Cell Lung Cancer
-
Los Angeles, California
- +9 more
Aug 16, 2022
Locally Advanced or Metastatic Breast Cancer Trial in China (GB491+ Fulvestrant, Placebo+Fulvestrant)
Recruiting
- Locally Advanced or Metastatic Breast Cancer
- GB491+ Fulvestrant
- Placebo+Fulvestrant
-
Bengbu, Anhui, China
- +53 more
Jun 10, 2022
Chronic Disease Management, Rheumatoid Arthritis Trial in Houston (Questionnaires, Facebook, Educational Website)
Active, not recruiting
- Chronic Disease Management
- Rheumatoid Arthritis
- Questionnaires
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 9, 2022
Health, Subjective, Food-drug Interaction Trial in Taipei (ABSK091 tablet)
Completed
- Health, Subjective
- Food-drug Interaction
- ABSK091 tablet
-
Taipei, TaiwanTri-Service General Hospital
Sep 5, 2022
Biliary Tract Adenocarcinoma Trial in Shanghai (HAIC, Gemcitabine, Oxaliplatin)
Enrolling by invitation
- Biliary Tract Adenocarcinoma
- HAIC
- +4 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
May 27, 2022
HPV Trial (Vaccination with PANHPVAX 10µg, Vaccination with PANHPVAX 40µg, Vaccination with PANHPVAX 100µg)
Not yet recruiting
- HPV
- Vaccination with PANHPVAX 10µg
- +2 more
- (no location specified)
Jun 1, 2022
Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)
Active, not recruiting
- Advanced Solid Tumours
- +4 more
- Durvalumab + Tremelimumab + metronomic Vinorelbine
-
Angers, France
- +8 more
Jun 1, 2022
Stigma, Social, Help-Seeking Behavior Trial in New York (Adjusted Content Intervention, Non-Adjusted Intervention Video)
Not yet recruiting
- Stigma, Social
- Help-Seeking Behavior
- Adjusted Content Intervention
- Non-Adjusted Intervention Video
-
New York, New YorkNew York State Psychiatric Institute
Apr 20, 2023
Diabetes, Type 2 Trial in Beijing (PF-06882961, Placebo)
Completed
- Diabetes Mellitus, Type 2
- PF-06882961
- Placebo
-
Beijing, ChinaPeking University Third Hospital
Mar 10, 2022
Healthy Trial in Tokyo (single 1-hour IV infusion of 0.8 mg/kg recAP, single 1-hour IV infusion of 1.6 mg/kg recAP, single
Completed
- Healthy
- single 1-hour IV infusion of 0.8 mg/kg recAP
- +4 more
-
Tokyo, JapanP-One Clinic, Keikokai Medical Corporation
Mar 11, 2022
Non Small Cell Lung Cancer Trial in Sweden (Standard systemic therapy + radiotherapy, Standard systemic therapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Standard systemic therapy + radiotherapy
- Standard systemic therapy
-
Gothenburg, Sweden
- +5 more
Nov 17, 2023
Melanoma Trial in East Melbourne, Heidelberg (NY-ESO-1 ISCOMATRIX® vaccine, Cyclophosphamide)
Completed
- Melanoma
- NY-ESO-1 ISCOMATRIX® vaccine
- Cyclophosphamide
-
East Melbourne, Victoria, Australia
- +1 more
Oct 3, 2022
Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago
Recruiting
- Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
- +2 more
- Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
-
Chicago, IllinoisNorthwestern University
Nov 16, 2022
Colorectal Tumors Trial (Pembrolizumab, Disitamab vedotin)
Not yet recruiting
- Colorectal Neoplasms
- Pembrolizumab
- Disitamab vedotin
- (no location specified)
Apr 19, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Letermovir)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Letermovir
- (no location specified)
Jan 23, 2023
Untreated Mantle Cell Lymphoma Trial in Suzhou (zanubrutinib and rituximab, BEAM pretreatment, zanubrutinib maintenance)
Recruiting
- Untreated Mantle Cell Lymphoma
- zanubrutinib and rituximab
- +2 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Aug 16, 2022
Chemo-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in United States
Recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- +2 more
- Palmidrol
- +2 more
-
Middletown, Connecticut
- +8 more
Aug 16, 2022
Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)
Completed
- Metastatic Solid Tumors
-
Scottsdale, Arizona
- +1 more
Jan 27, 2022
Long COVID, Chronic Pain, Musculoskeletal Pain Trial in Valladolid (0)
Recruiting
- Long COVID
- +2 more
- 0
-
Valladolid, SpainUniversidad de Valladolid
Jun 7, 2023
Breast Cancer Trial in Washington, Baltimore (Stereotactic Body Radiation SBRT)
Recruiting
- Breast Cancer
- Stereotactic Body Radiation SBRT
-
Washington, District of Columbia
- +1 more
Jan 24, 2022